chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Heart rate increased, Pyrexia, Vomiting
Clinical narrative: heart rate High; She Vomited; Temperature 101.3; Fatigued; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (heart rate High), VOMITING (She Vomited), PYREXIA (Temperature 101.3) and FATIGUE (Fatigued) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Dec-2020, the patient experienced HEART RATE INCREASED (heart rate High), VOMITING (She Vomited), PYREXIA (Temperature 101.3) and FATIGUE (Fatigued). On 30-Dec-2020, HEART RATE INCREASED (heart rate High), VOMITING (She Vomited), PYREXIA (Temperature 101.3) and FATIGUE (Fatigued) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Dec-2020, Body temperature: 101.3 High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported she is on immunosuppressants. Patient used acetaminophen for treatment.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: itching; rash size of 1"x2", grew to 3"x5" couple days later; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash size of 1"x2", grew to 3"x5" couple days later) and PRURITUS (itching) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included LEVOTHYROXINE SODIUM (THYROXINE) and ESTRADIOL for an unknown indication.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced RASH (rash size of 1"x2", grew to 3"x5" couple days later). On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PRURITUS (itching). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, RASH (rash size of 1"x2", grew to 3"x5" couple days later) and PRURITUS (itching) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) dosing remained unchanged.       This case was linked to MOD21-022477 (E2B Linked Report). This case was linked to MOD-2021-037858 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Jan-2021: Customer provided additional information, date of birth, vaccine lot number, event specifics and treatment information; Sender's Comments:  MOD21-022477:same reporter, additional info added for dose 1
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth, Vaccination site pain
Clinical narrative: Warm to touch; Itchy; Injection site was swollen; Red; Initially was sore; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Warm to touch), INJECTION SITE PRURITUS (Itchy), INJECTION SITE SWELLING (Injection site was swollen), VACCINATION SITE PAIN (Initially was sore) and INJECTION SITE ERYTHEMA (Red) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     The patient's past medical history included Lung operation NOS (lung surgery). Concurrent medical conditions included Drug allergy (to codeine), Food allergy (to strawberries) and Food allergy (to apples). Concomitant products included ELoquist, METOPROLOL, AMIODARONE, CITALOPRAM HYDROBROMIDE (CELESTA), SIMVASTATIN (ZOCOR) and ASCORBIC ACID (VIT C) for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE PAIN (Initially was sore). On 17-Jan-2021, the patient experienced INJECTION SITE WARMTH (Warm to touch), INJECTION SITE PRURITUS (Itchy), INJECTION SITE SWELLING (Injection site was swollen) and INJECTION SITE ERYTHEMA (Red). At the time of the report, INJECTION SITE WARMTH (Warm to touch), INJECTION SITE PRURITUS (Itchy), INJECTION SITE SWELLING (Injection site was swollen), VACCINATION SITE PAIN (Initially was sore) and INJECTION SITE ERYTHEMA (Red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported not using any medications for treatment.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site induration, Vaccination site pain
Clinical narrative: The day after the shot he felt it was hard if he pressed on the area; Felt kind of sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (The day after the shot he felt it was hard if he pressed on the area) and VACCINATION SITE PAIN (Felt kind of sore) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced VACCINATION SITE INDURATION (The day after the shot he felt it was hard if he pressed on the area) and VACCINATION SITE PAIN (Felt kind of sore). On 17-Jan-2021, VACCINATION SITE INDURATION (The day after the shot he felt it was hard if he pressed on the area) and VACCINATION SITE PAIN (Felt kind of sore) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: slight arm soreness this morning; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (slight arm soreness this morning) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNK) for COVID-19 vaccination.     The patient's past medical history included Bypass surgery (Double bypass). Concurrent medical conditions included Diabetes.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced PAIN IN EXTREMITY (slight arm soreness this morning). At the time of the report, PAIN IN EXTREMITY (slight arm soreness this morning) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The reporter mentioned she did not remember the medications he takes on daily basis. No treatment medications were used.   This case was linked to MOD21-07646 (E2B Linked Report).; Sender's Comments:  MOD21-07646:
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Oropharyngeal pain, Pain, Rhinorrhoea
Clinical narrative: Runny Nose; cough; Sore Throat; body aches; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RHINORRHOEA (Runny Nose), COUGH (cough), OROPHARYNGEAL PAIN (Sore Throat) and PAIN (body aches) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jan-2021, the patient experienced RHINORRHOEA (Runny Nose), COUGH (cough), OROPHARYNGEAL PAIN (Sore Throat) and PAIN (body aches). At the time of the report, RHINORRHOEA (Runny Nose), COUGH (cough), OROPHARYNGEAL PAIN (Sore Throat) and PAIN (body aches) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Patient reported taking coricidin for treatment, after which symptoms got better.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pain
Clinical narrative: sore all over; Feeling tired; chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (sore all over), FATIGUE (Feeling tired), CHILLS (chills) and HEADACHE (headache) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced PAIN (sore all over), FATIGUE (Feeling tired), CHILLS (chills) and HEADACHE (headache). On 16-Jan-2021, PAIN (sore all over), FATIGUE (Feeling tired), CHILLS (chills) and HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient mentioned she's wondering if that's ( reaction to the shot ) because she just got over having the virus about 8 days. She also mentioned My last quarantine day was 06Jan2021 and I had the shot on 14Jan2021. I read that you have to wait 90 days, but it's too late for me. Patient reported taking ibuprofen on 15Jan2021 and laid around to rest all day.
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia
Clinical narrative: loss of taste; Loss of smell; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (loss of taste) and ANOSMIA (Loss of smell) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced AGEUSIA (loss of taste) and ANOSMIA (Loss of smell). At the time of the report, AGEUSIA (loss of taste) and ANOSMIA (Loss of smell) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment medications were unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Red at the injection site; very swollen at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Red at the injection site) and INJECTION SITE SWELLING (very swollen at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Epidural injection (received epidural steroid injection) since an unknown date.    On 08-Jan-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE ERYTHEMA (Red at the injection site) and INJECTION SITE SWELLING (very swollen at injection site). At the time of the report, INJECTION SITE ERYTHEMA (Red at the injection site) and INJECTION SITE SWELLING (very swollen at injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Erythema, Pain in extremity, Pruritus
Clinical narrative: itch in other areas. finger, and back; a little reddish; scratching like crazy; BP was very high at 181 and normally 135; Arm sore for 2-3 days no big deal; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE INCREASED (BP was very high at 181 and normally 135), PAIN IN EXTREMITY (Arm sore for 2-3 days no big deal), PRURITUS (itch in other areas. finger, and back), ERYTHEMA (a little reddish) and VACCINATION SITE PRURITUS (scratching like crazy) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure inadequately controlled. Concomitant products included AMLODIPINE for Blood pressure inadequately controlled.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm sore for 2-3 days no big deal). On 15-Jan-2021, the patient experienced BLOOD PRESSURE INCREASED (BP was very high at 181 and normally 135), ERYTHEMA (a little reddish) and VACCINATION SITE PRURITUS (scratching like crazy). On 17-Jan-2021, the patient experienced PRURITUS (itch in other areas. finger, and back). On 12-Jan-2021, PAIN IN EXTREMITY (Arm sore for 2-3 days no big deal) outcome was unknown. On 17-Jan-2021, VACCINATION SITE PRURITUS (scratching like crazy) outcome was unknown. At the time of the report, BLOOD PRESSURE INCREASED (BP was very high at 181 and normally 135), PRURITUS (itch in other areas. finger, and back) and ERYTHEMA (a little reddish) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, Blood pressure measurement: 181 (High) was very high , normally around 135.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The treatment medication used was diphenhydramine on and around the site of injection. Also patient took diphenhydramine on 16Jan2021 night.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: itch in other areas. finger, and back; a little reddish; scratching like crazy; BP was very high at 181 and normally 135; Arm sore for 2-3 days no big deal; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE INCREASED (BP was very high at 181 and normally 135), PAIN IN EXTREMITY (Arm sore for 2-3 days no big deal), PRURITUS (itch in other areas. finger, and back), ERYTHEMA (a little reddish) and VACCINATION SITE PRURITUS (scratching like crazy) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure inadequately controlled. Concomitant products included AMLODIPINE for Blood pressure inadequately controlled.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm sore for 2-3 days no big deal). On 15-Jan-2021, the patient experienced BLOOD PRESSURE INCREASED (BP was very high at 181 and normally 135), ERYTHEMA (a little reddish) and VACCINATION SITE PRURITUS (scratching like crazy). On 17-Jan-2021, the patient experienced PRURITUS (itch in other areas. finger, and back). On 12-Jan-2021, PAIN IN EXTREMITY (Arm sore for 2-3 days no big deal) outcome was unknown. On 17-Jan-2021, VACCINATION SITE PRURITUS (scratching like crazy) outcome was unknown. At the time of the report, BLOOD PRESSURE INCREASED (BP was very high at 181 and normally 135), PRURITUS (itch in other areas. finger, and back) and ERYTHEMA (a little reddish) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, Blood pressure measurement: 181 (High) was very high , normally around 135.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The treatment medication used was diphenhydramine on and around the site of injection. Also patient took diphenhydramine on 16Jan2021 night.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Pain in extremity, Pyrexia, Vomiting
Clinical narrative: Diarrhea; Fever; Chills; Vomiting; sore arm again; very sore arm; This spontaneous case was reported by a health care professional and describes the occurrence of PAIN IN EXTREMITY (very sore arm), PAIN IN EXTREMITY (sore arm again), DIARRHOEA (Diarrhea), PYREXIA (Fever) and CHILLS (Chills) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CITALOPRAM HYDROBROMIDE (CELEXA [CITALOPRAM HYDROBROMIDE]) and MELOXICAM (MOBIC) for an unknown indication.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced PAIN IN EXTREMITY (very sore arm). On 15-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm again). On 18-Jan-2021, the patient experienced DIARRHOEA (Diarrhea), PYREXIA (Fever), CHILLS (Chills) and VOMITING (Vomiting). On 09-Jan-2021, PAIN IN EXTREMITY (very sore arm) had resolved with sequelae. At the time of the report, PAIN IN EXTREMITY (sore arm again), DIARRHOEA (Diarrhea), PYREXIA (Fever), CHILLS (Chills) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Rash macular, SARS-CoV-2 test positive
Clinical narrative: Big blotchy rash; Case reference number MOD-2021-008930 is a spontaneous case report sent by a Non-Health Professional on 18-JAN-2021 00:00:00 .  On  24/DEC/2020  the patient started taking Moderna COVID-19 Vaccine for COVID-19 vaccination. Some  days  later,  the patient developed Big blotchy rash.the patient also developed Diagnosed with COVID after 1st vaccine. Relevant laboratory results included   and relevant physical signs were not provided.The patient experienced the following serious criteria:. The eventual diagnosis made on was Rash macular . The Non-Health Professional did not declare any relatedness between Big blotchy rash and Moderna COVID-19 Vaccine.  The medical reviewer may provide a case evaluation statement, including other possible etiological and confounding factors, e.g. (only limited information has been obtained so far, it is difficult to assess the cause and effect relationship; the co-medications y and x should also be considered causative as the reported event is labeled for both drugs; the company's view is the event is not due to the drug for the following reasons  (probably due to pre existing disease); there is no plausible mechanism to implicate the drug.  .    Narrative (for narratives and signal review) Brief 3 line summary of above for ADR listing: Report Source- Non-Health Professional,  Age-  ,  Sex- Female,  Suspect Drug- Moderna COVID-19 Vaccine,  Treatment-    Diagnosis\Outcome-  .
Sex: F
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: Chest pain; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No Adverse Event (No reported medical history).    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced CHEST PAIN (Chest pain). At the time of the report, CHEST PAIN (Chest pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information provided. No treatment information provided.; Sender's Comments: Based on reporter's causality (and any other explanation worth adding) the event is assessed as unlikely related to mRNA-1273.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site rash
Clinical narrative: rash measuring 3 inches wide and 4 inches long at the injection site; Redness at the injection site; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE RASH (rash measuring 3 inches wide and 4 inches long at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jan-2021, the patient experienced VACCINATION SITE RASH (rash measuring 3 inches wide and 4 inches long at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site). At the time of the report, VACCINATION SITE RASH (rash measuring 3 inches wide and 4 inches long at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant information provided. No treatment information provided.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Night sweats, Pyrexia, Rash
Clinical narrative: rash on both arms; Clothes and sheets were soaked; headache; fever; This spontaneous case was reported by an other health care professional and describes the occurrence of RASH (rash on both arms), NIGHT SWEATS (Clothes and sheets were soaked), HEADACHE (headache) and PYREXIA (fever) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced RASH (rash on both arms), NIGHT SWEATS (Clothes and sheets were soaked), HEADACHE (headache) and PYREXIA (fever). On 17-Jan-2021, NIGHT SWEATS (Clothes and sheets were soaked) had resolved. On 18-Jan-2021, HEADACHE (headache) and PYREXIA (fever) had resolved. At the time of the report, RASH (rash on both arms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment information provided.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site induration, Injection site pruritus
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of injection site induration (welt at injection site) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history provided. On Jan 8, 2021, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced injection site induration (welt at injection site). At the time of the report, injection site induration (welt at injection site): not resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medicine or treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dry mouth, Pharyngeal swelling, Swelling face
Clinical narrative: swelling of the face; swelling of the throat; dry mouth; dizziness; This spontaneous case was reported by a consumer and describes the occurrence of   in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medication history reported).    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant information provided. No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Tested positive for Covid; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of COVID-19 (Tested positive for Covid) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.     On 07-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jan-2021, the patient experienced COVID-19 (Tested positive for Covid). At the time of the report, COVID-19 (Tested positive for Covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Jan-2021, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.    No Treatment information for the event was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 18-Jan-2021 and was forwarded to Moderna on 18-Jan-2021.    This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of COVID-19 (Tested positive for Covid) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.     On 07-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jan-2021, the patient experienced COVID-19 (Tested positive for Covid). At the time of the report, COVID-19 (Tested positive for Covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Jan-2021, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.    No Treatment information for the event was provided.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Vaccination site pain, Vaccination site rash
Clinical narrative: Chest pain; Rash on his back; Pain in armpit; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash on his back), VACCINATION SITE PAIN (Pain in armpit) and CHEST PAIN (Chest pain) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K202A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (Rash on his back), VACCINATION SITE PAIN (Pain in armpit) and CHEST PAIN (Chest pain). At the time of the report, VACCINATION SITE RASH (Rash on his back), VACCINATION SITE PAIN (Pain in armpit) and CHEST PAIN (Chest pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: pain; redness; itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain), VACCINATION SITE ERYTHEMA (redness) and VACCINATION SITE PRURITUS (itching) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On an unknown date, the patient experienced VACCINATION SITE PAIN (pain), VACCINATION SITE ERYTHEMA (redness) and VACCINATION SITE PRURITUS (itching). At the time of the report, VACCINATION SITE PAIN (pain), VACCINATION SITE ERYTHEMA (redness) and VACCINATION SITE PRURITUS (itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No conmeds reported  No treatment information provided.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site movement impairment
Clinical narrative: extreme left arm pain; can't lift arm over her head; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (extreme left arm pain) and VACCINATION SITE MOVEMENT IMPAIRMENT (can't lift arm over her head) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: FLU (Patient took flu and Shingles vaccine 2months ago).    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced PAIN IN EXTREMITY (extreme left arm pain) and VACCINATION SITE MOVEMENT IMPAIRMENT (can't lift arm over her head). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Pain, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (extreme left arm pain) and VACCINATION SITE MOVEMENT IMPAIRMENT (can't lift arm over her head) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Skin exfoliation
Clinical narrative: Hands peeling/Fingers and tip of nose peeling; This spontaneous case was reported by a consumer and describes the occurrence of SKIN EXFOLIATION (Hands peeling/Fingers and tip of nose peeling) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SKIN EXFOLIATION (Hands peeling/Fingers and tip of nose peeling). At the time of the report, SKIN EXFOLIATION (Hands peeling/Fingers and tip of nose peeling) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No relevant concomitant medications were reported.  Treatment medication included vitamin E lotion.
Sex: F
Vaccine: COVID19
Symptoms: Mouth ulceration, Viral infection
Clinical narrative: ulcers throughout my mouth; viral ulcer; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MOUTH ULCERATION (ulcers throughout my mouth) and VIRAL INFECTION (viral ulcer) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced MOUTH ULCERATION (ulcers throughout my mouth) and VIRAL INFECTION (viral ulcer). The patient was treated with ACYCLOVIR [ACICLOVIR] for Mouth ulcer and Viral infection, at an unspecified dose and frequency and PREDNISONE for Mouth ulcer and Viral infection, at an unspecified dose and frequency. At the time of the report, MOUTH ULCERATION (ulcers throughout my mouth) and VIRAL INFECTION (viral ulcer) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Other treatment medication included magic mouthwash.
Sex: U
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Numbness in arm, foream and fingers; Tingling  in arm, foream and fingers; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness in arm, foream and fingers) and PARAESTHESIA (Tingling  in arm, foream and fingers) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     The patient's past medical history included No adverse event (No Medical History reported).    On 03-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jan-2021, the patient experienced HYPOAESTHESIA (Numbness in arm, foream and fingers) and PARAESTHESIA (Tingling  in arm, foream and fingers). At the time of the report, HYPOAESTHESIA (Numbness in arm, foream and fingers) and PARAESTHESIA (Tingling  in arm, foream and fingers) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information provided. No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site mass
Clinical narrative: Red Bump on Injection Site; Soreness on Arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Red Bump on Injection Site) and PAIN IN EXTREMITY (Soreness on Arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (Red Bump on Injection Site) and PAIN IN EXTREMITY (Soreness on Arm). At the time of the report, VACCINATION SITE MASS (Red Bump on Injection Site) and PAIN IN EXTREMITY (Soreness on Arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Arms were sore; This spontaneous case was reported by an other and describes the occurrence of INJECTION SITE PAIN (Arms were sore) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO Medical History Information was reported.     On 12-Jan-2021 at 1:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced INJECTION SITE PAIN (Arms were sore). On 13-Jan-2021, INJECTION SITE PAIN (Arms were sore) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant Concomitant medications were reported.   No Treatment information for the event was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 18-Jan-2021 and was forwarded to Moderna on 18-Jan-2021.    This spontaneous case was reported by an other and describes the occurrence of INJECTION SITE PAIN (Arms were sore) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO Medical History Information was reported.     On 12-Jan-2021 at 1:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced INJECTION SITE PAIN (Arms were sore). On 13-Jan-2021, INJECTION SITE PAIN (Arms were sore) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant Concomitant medications were reported.   No Treatment information for the event was provided.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Headache, Pain in extremity
Clinical narrative: Tested positive for COVID; Headache; Cough; sore arm; This spontaneous case was reported by a health care professional and describes the occurrence of PAIN IN EXTREMITY (sore arm), HEADACHE (Headache), COUGH (Cough) and COVID-19 (Tested positive for COVID) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included PHENTERMINE HYDROCHLORIDE, TOPIRAMATE (QSYMIA) and PAROXETINE.    On 22-Dec-2020, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Dec-2020, the patient experienced PAIN IN EXTREMITY (sore arm). On 31-Dec-2020, the patient experienced HEADACHE (Headache) and COUGH (Cough). On 01-Jan-2021, the patient experienced COVID-19 (Tested positive for COVID). On 23-Dec-2020, PAIN IN EXTREMITY (sore arm) outcome was unknown. At the time of the report, HEADACHE (Headache), COUGH (Cough) and COVID-19 (Tested positive for COVID) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Hyperhidrosis, Nausea, Pyrexia
Clinical narrative: Lymph nodes in arm were sore; Arm sore/Site of shot sore; Fever; Chills/Shivering very hard; Nausea; Headache; Fever broke twice and the 2nd time it broke, she ended up wetting the bed; Felt so sick/Sick for 2 days; A spontaneous report was received from a consumer concerning a 62 year old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced vaccination site lymphadenopathy, vaccination site pain, pyrexia, chills, headache, nausea ,vaccination complication, hyperhidrosis.  The patient's medical history was COVID-19 in Sep 2020.  Concomitant medications were metoprolol, lisinopril, bumetidine, amlodipine, potassium chloride, Synthroid ,baby aspirin ,vitamins and supplements.  On 13-jan-2021 prior to the onset of events, the  patient received her first of two planned doses of mRNA-1273(Batch Number 011J20A) on left arm in intramuscular route for COVID-19 infection.  On 13-jan-2021 the patient experienced arm was so sore, fever, chills, headache, lymph nodes on my arm were sore, site of the shot was sore, was in bed for 2 days, fever broke twice, and 2nd time I ended up wetting the bed, shivering so hard, sick for 2 days.  Treatment taken was Ibuprofen, Tylenol. Action taken with mRNA-1273 in response to the events was not reported.  On 15-jan-2021 the outcome of all events were Resolved/recovered.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication, Vaccination site lymphadenopathy, Vaccination site pain
Clinical narrative: Lymph nodes in arm were sore; Arm sore/Site of shot sore; Fever; Chills/Shivering very hard; Nausea; Headache; Fever broke twice and the 2nd time it broke, she ended up wetting the bed; Felt so sick/Sick for 2 days; A spontaneous report was received from a consumer concerning a 62 year old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced vaccination site lymphadenopathy, vaccination site pain, pyrexia, chills, headache, nausea ,vaccination complication, hyperhidrosis.  The patient's medical history was COVID-19 in Sep 2020.  Concomitant medications were metoprolol, lisinopril, bumetidine, amlodipine, potassium chloride, Synthroid ,baby aspirin ,vitamins and supplements.  On 13-jan-2021 prior to the onset of events, the  patient received her first of two planned doses of mRNA-1273(Batch Number 011J20A) on left arm in intramuscular route for COVID-19 infection.  On 13-jan-2021 the patient experienced arm was so sore, fever, chills, headache, lymph nodes on my arm were sore, site of the shot was sore, was in bed for 2 days, fever broke twice, and 2nd time I ended up wetting the bed, shivering so hard, sick for 2 days.  Treatment taken was Ibuprofen, Tylenol. Action taken with mRNA-1273 in response to the events was not reported.  On 15-jan-2021 the outcome of all events were Resolved/recovered.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: Redness -Each day has gotten larger. The redness increased each day down towards the elbowand under you arm.; Itching; Red spot; A little swelling; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Red spot), VACCINATION SITE SWELLING (A little swelling), VACCINATION SITE PAIN (Soreness), ERYTHEMA (Redness -Each day has gotten larger. The redness increased each day down towards the elbowand under you arm.) and PRURITUS (Itching) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032H20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red spot), VACCINATION SITE SWELLING (A little swelling) and VACCINATION SITE PAIN (Soreness). On 15-Jan-2021, the patient experienced ERYTHEMA (Redness -Each day has gotten larger. The redness increased each day down towards the elbowand under you arm.) and PRURITUS (Itching). On 06-Jan-2021, VACCINATION SITE PAIN (Soreness) had resolved. On 10-Jan-2021, VACCINATION SITE ERYTHEMA (Red spot) and VACCINATION SITE SWELLING (A little swelling) had resolved. At the time of the report, ERYTHEMA (Redness -Each day has gotten larger. The redness increased each day down towards the elbowand under you arm.) and PRURITUS (Itching) had not resolved. Not Provided          On 13-Apr-2021, the patient reported that "things are fine now" and declined further follow-up.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: swelling at the injection site; redness at the injection site; pain at the injection site; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE SWELLING (swelling at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site) and VACCINATION SITE PAIN (pain at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 Vaccine.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE SWELLING (swelling at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site) and VACCINATION SITE PAIN (pain at the injection site). At the time of the report, VACCINATION SITE SWELLING (swelling at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site) and VACCINATION SITE PAIN (pain at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   MRI with contrast dye.  No treatment information provided.  No conmeds reported.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on his trunk and face; Rash on his trunk and face; Developed a rash; This spontaneous case was reported by a physician and describes the occurrence of the first episode of RASH (Rash on his trunk and face), the second episode of RASH (Rash on his trunk and face) and RASH (Developed a rash) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jan-2021, the patient experienced the first episode of RASH (Rash on his trunk and face), the second episode of RASH (Rash on his trunk and face) and RASH (Developed a rash). At the time of the report, last episode of RASH (Rash on his trunk and face) and RASH (Developed a rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant information provided. No treatment information provided.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Sensory loss, Swelling face
Clinical narrative: lip swelling, entire top lip up to bottom of her nostrils was both swollen and numb; left side of cheek numb, entire top lip up to bottom of nostrils was numb; This spontaneous case was reported by a consumer and describes the occurrence of   in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.  Treatment included putting ice on her lip all day.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Tested positive for COVID; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no reported medical history).    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jan-2021, the patient experienced COVID-19 (Tested positive for COVID). At the time of the report, COVID-19 (Tested positive for COVID) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.